Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck – WSJ – The Wall Street Journal
A Japanese company has started human trials of the first once-a-day pill for Covid-19 patients, joining
Pfizer Inc.
PFE 0.51%
and
Merck
MRK 1.32%
& Co. in the race to find treatments for the disease.Osaka-based
Shionogi
4507 0.68%
& Co., which helped…
